Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Sunshine Bio Investments World Launches Funding Initiatives in Multi-Billion Dollar North American Markets Serving Stem Cell Research, Genomics, Prote

Abstract:
Sunshine Bio Investments World, a privately held Canadian company (www.sunshinebioworld.com), has established U.S. headquarters in Miami and initiated venture funding for a variety of biotech, pharmaceutical and medical device companies active in the multi-billion dollar North American biotech environment.

Sunshine Bio Investments World Launches Funding Initiatives in Multi-Billion Dollar North American Markets Serving Stem Cell Research, Genomics, Prote

Miami, FL | Posted on November 20th, 2008

Miami operations are located at 5600 Collins Avenue, Suite 17C, Miami, Florida, 33140. Telephone is 305-433-2121.

According to Michael Di Turi, Sunshine Bio Investments World President and CEO, "Most investment banks in the North American markets do not closely follow small and mid-cap biotech and biodefense sectors. At the same time, many analysts are not adequately qualified to fairly and thoroughly evaluate the potential of these companies.

"Pharmagenomics, nanomedicine and regenerative medicine will predict, prevent and cure life-threatening viruses and diseases," continued Mr. Di Turi. "Sunshine Bio Investments World partners are at the forefront of 21st century technologies. We are seeking partners and alliances to develop, market and distribute products and solutions to improve the health, safety and security of individuals worldwide," he said.

Sunshine Bio Investments World Companies Are Already Making Breakthroughs, Contributing to Respective Industries

Mr. Di Turi added, "Companies we are presently funding are located across Canada, California and Florida, contributing to industry knowledge, and making significant scientific breakthroughs. Areas of expertise include commercialization of drug-based therapies to treat central nervous system diseases, programs to repair neurological function lost due to disease or injury, single-walled carbon nanotubes, nanomaterials and other advanced materials for high value-added applications; and clinically proven procedures available for the cryogenic storage of umbilical cord blood (UCB)."

####

For more information, please click here

Contacts:
Tony Sciangula
Sunshine Bio Investments World
786-704-4509

or
Steven Swartz
SIZZLE PR
978-524-9595

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015

Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015

'Bulletproof' battery: Kevlar membrane for safer, thinner lithium rechargeables January 28th, 2015

Spider electro-combs its sticky nano-filaments January 28th, 2015

Openings/New facilities/Groundbreaking/Expansion

JPK opens new expanded offices in Berlin to meet the growing demand for products worldwide January 28th, 2015

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Ref signals deep impact as EPSRC announces £30 million for impact acceleration accounts (IAA) January 21st, 2015

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015

QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015

Pixelligent Closes $5.5 Million in Funding: Capital Will Be Used to Support Global Customer Growth December 12th, 2014

Investments/IPO's/Splits

Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015

Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015

Announcements

Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015

Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015

'Bulletproof' battery: Kevlar membrane for safer, thinner lithium rechargeables January 28th, 2015

Spider electro-combs its sticky nano-filaments January 28th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE